Profil
Therésa K.
Dixon worked as a Director of National Health Economics at Smith & Nephew plc and as a Senior Associate at Covance Health Economics & Outcomes Services, Inc. She also worked as a Vice President of Government Affairs at Shire Regenerative Medicine, Inc. and as a General Manager of Market Access & Reimbursement at Osiris Therapeutics, Inc. Dixon received her undergraduate degree from the University of Missouri, her graduate degree from Marymount University, and her MBA from the University of Maryland.
Anciens postes connus de Therésa K. Dixon
| Sociétés | Poste | Fin |
|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2016 |
| Covance Health Economics & Outcomes Services, Inc. | Corporate Officer/Principal | - |
| SMITH & NEPHEW PLC | Corporate Officer/Principal | - |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Public Communications Contact | - |
Formation de Therésa K. Dixon
| University of Missouri | Undergraduate Degree |
| Marymount University | Graduate Degree |
| University of Maryland | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SMITH & NEPHEW PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Shire Regenerative Medicine, Inc.
Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Health Technology |
| Covance Health Economics & Outcomes Services, Inc. |
